# –ë–∏–Ω–∞—Ä–∏–∑–∞—Ü–∏—è –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏

##### –ö–î –∏ -log(–ö–î)
–ù–∞–ø–∏—à–∏ –æ —Ç–æ–º, –ø–æ—á–µ–º—É –º—ã –≤–∑—è–ª–∏ –ø–æ—Ä–æ–≥ –¥–ª—è –±–∏–Ω–∞—Ä–∏–∑–∞—Ü–∏–∏ ‚Äî –∫–æ–Ω—Å—Ç–∞–Ω—Ç—É –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ 100 –Ω–∞–Ω–æ–º–æ–ª—å –ö–î = 100–Ω–ú (–ø—Ä–∏–≤–µ–¥–∏ —Å—Å—ã–ª–∫–∏ –Ω–∞ –¥–≤–µ-—Ç—Ä–∏ –Ω–∞—É—á–Ω—ã–µ —Å—Ç–∞—Ç—å–∏, –∫–æ—Ç–æ—Ä—ã–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç —Ç–∞–∫–æ–µ –∑–Ω–∞—á–µ–Ω–∏–µ, –∫–∞–∫ –ø–æ—Ä–æ–≥ —Ö–æ—Ä–æ—à–µ–π —Å–≤—è–∑—ã–≤–∞–µ–º–æ—Å—Ç–∏. –ñ–µ–ª–∞—Ç–µ–ª—å–Ω–æ –¥–ª—è ML-–¥–∞—Ç–∞—Å–µ—Ç–æ–≤). –í–æ—Ç –Ω–∞–ø—Ä–∏–º–µ—Ä Foote & Eisen, PNAS, 2000
 ‚Äî –ø–æ—Ä–æ–≥ 100 –Ω–ú –∫–∞–∫ ¬´therapeutically relevant affinity ceiling¬ª.
–°–≤—è–∑—å –º–µ–∂–¥—É –Ω–µ–∫–æ—Ç–æ—Ä—ã–º–∏ —Ç–∏–ø–∞–º–∏ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –∏ –ö–î –æ—á–µ–Ω—å —Å–ª–æ–∂–Ω–∞ –∏ —Å–∏–ª—å–Ω–æ –∑–∞–≤–∏—Å–∏—Ç –æ—Ç –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö —É—Å–ª–æ–≤–∏–π, –ø–æ—ç—Ç–æ–º—É –Ω–∞–ø—Ä—è–º—É—é –ø—Ä–µ–æ–±—Ä–∞–∑–æ–≤–∞—Ç—å –∏—Ö –∑–Ω–∞—á–µ–Ω–∏–µ –≤ –∫–æ–Ω—Å—Ç–∞–Ω—Ç—É –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ. –ì–¥–µ —ç—Ç–æ –±—ã–ª–æ –≤–æ–∑–º–æ–∂–Ω–æ –ø–æ–ø—Ä–æ–±–æ–≤–∞–ª–∏ –≤–∑—è—Ç—å –ø–æ—Ä–æ–≥–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ —Å—Ä–∞–≤–Ω–∏–º—ã–µ —Å –ö–î = 100–Ω–ú, —á—Ç–æ —Å–æ–æ—Ç–≤–µ—Ç—Å–≤—É–µ—Ç -log(–ö–î) = 7

–¢–∞–±–ª–∏—Ü–∞ X. –†–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ affinity_type –≤ –¥–∞—Ç–∞—Å–µ—Ç–µ ASD. 

##### fuzzy
–û–ø–∏—à–∏ –Ω–µ–º–Ω–æ–≥–æ –¥–∞—Ç–∞—Å–µ—Ç buzz (–≤–æ—Ç –ø–æ —ç—Ç–æ–π —Å—Å—ã–ª–∫–µ –µ–≥–æ –º–æ–∂–Ω–æ –Ω–∞–π—Ç–∏)
–ø–æ—Ä–æ–≥–∏ –¥–ª—è –∫–ª–∞—Å—Å–æ–≤ ‚Äòhigh‚Äô, ‚Äòmedium‚Äô –∏ ‚Äòlow‚Äô –≤ –Ω–∞–±–æ—Ä–µ –¥–∞–Ω–Ω—ã—Ö HER2-aff-large –±—ã–ª–∏ –≤—ã–±—Ä–∞–Ω—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–æ—Ä—Ç–∏—Ä–æ–≤–∫–∏ –∫–ª–µ—Ç–æ–∫ –ø–æ —É—Ä–æ–≤–Ω—é —Å–≤—è–∑—ã–≤–∞–Ω–∏—è —Å –∞–Ω—Ç–∏–≥–µ–Ω–æ–º HER2, –∞ –Ω–µ –ø–æ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–º –∑–Ω–∞—á–µ–Ω–∏—è–º –ö–î. [Chinery et al, 2024; doi:10.1101/2024.03.26.586756]
High-affinity ‚Äî —Å–∞–º–∞—è —è—Ä–∫–∞—è (PE-positive) –ø–æ–ø—É–ª—è—Ü–∏—è;
Medium-affinity ‚Äî —Å—Ä–µ–¥–Ω—è—è –ø–æ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ—Å—Ç–∏ —Ñ–ª—É–æ—Ä–µ—Å—Ü–µ–Ω—Ü–∏–∏;
Low-affinity ‚Äî —Å–ª–∞–±–æ—Å–≤—è–∑—ã–≤–∞—é—â–∞—è –ø–æ–ø—É–ª—è—Ü–∏—è.
–í –æ–±—â–µ–º –Ω–∞–ø–∏—à–∏—Ç–µ, —á—Ç–æ —ç—Ç–æ –Ω–µ –≤—Ö–æ–¥–∏—Ç –≤ scope –Ω–∞—à–µ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ —á—Ç–æ —Ç–∞–∫ –∫–∞–∫ —Ç–æ—á–Ω–æ–≥–æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è —Å –∫–æ–Ω—Å—Ç–∞–Ω—Ç–æ–π –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É –Ω–∞—Å –Ω–µ—Ç, –º—ã –±–µ—Ä–µ–º —Å–≤—è–∑—É–µ–º–æ—Å—Ç—å h (high), —á—Ç–æ–±—ã –±—ã—Ç—å —É–≤–µ—Ä–µ–Ω–Ω—ã–º–∏, —á—Ç–æ –æ–Ω–∞ –±—É–¥–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–π.

##### bool
–¢—É—Ç –Ω–∞–ø–∏—à–∏ —á—Ç–æ –º–Ω–æ–≥–æ –¥–∞—Ç–∞—Å–µ—Ç–æ–≤ –∏ –≤–µ–∑–¥–µ –ø–æ—Ä–æ–≥–∏ —Ä–∞–∑–Ω—ã–µ (—á—Ç–æ –≤ –Ω–∞—à–µ–π —Ä–∞–±–æ—Ç–µ –æ–Ω–∏ –≤—Å—ë —Ä–∞–≤–Ω–æ –≤—Å–µ –æ—Ç—Ñ–∏–ª—å—Ç—Ä–æ–≤–∞–ª–∏—Å—å, –ø–æ—ç—Ç–æ–º—É –Ω–∞–º —ç—Ç–æ –Ω–µ —Ç–∞–∫ –≤–∞–∂–Ω–æ, –∫–∞–∫–∏–µ —Ç–∞–º –ø–æ—Ä–æ–≥–∏), –¥–∞—Ç—å —Å—Å—ã–ª–∫—É –Ω–∞ —Ç–∞–±–ª–∏—Ü—É –≤—ã—à–µ


##### alphaseq 
AlphaSeq affinity ‚Äî —ç—Ç–æ —á–∏—Å–ª–µ–Ω–Ω–∞—è –æ—Ü–µ–Ω–∫–∞ —Å–∏–ª—ã —Å–≤—è–∑—ã–≤–∞–Ω–∏—è (–∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏) –ø–∞—Ä—ã –±–µ–ª–∫–æ–≤, –ø–æ–ª—É—á–µ–Ω–Ω–∞—è –≤ –≤—ã—Å–æ–∫–æ–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ–º –¥—Ä–æ–∂–∂–µ–≤–æ–º assay AlphaSeq (–æ–Ω –∂–µ ‚Äúyeast synthetic agglutination / SynAg‚Äù –≤ –∞–∫–∞–¥–µ–º–∏—á–µ—Å–∫–∏—Ö –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö). –í –æ—Ç–∫—Ä—ã—Ç—ã—Ö –¥–∞—Ç–∞—Å–µ—Ç–∞—Ö A-Alpha Bio –∏ –≤ data descriptor –¥–ª—è –∞–Ω—Ç–∏—Ç–µ–ª –æ–±—ã—á–Ω–æ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å —Ä–µ–ø–æ—Ä—Ç–∏—Ä—É–µ—Ç—Å—è –∫–∞–∫: log10(–æ—Ü–µ–Ω—ë–Ω–Ω–æ–≥–æ –ö–î –≤ nM) [Agarwal et al., 2024; doi:10.1101/2024.11.11.622872][https://huggingface.co/datasets/aalphabio/open-alphaseq]

–ó–Ω–∞—á–∏—Ç
–ü–æ—Ä–æ–≥ < 2 –∑–Ω–∞—á–∏—Ç –∞—Ñ—Ñ–∏–Ω–Ω—ã–µ –∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç –ö–î < 100 nM



##### log_enrichment
`Log_enrichment` –æ—Ç—Ä–∞–∂–∞–µ—Ç, –Ω–∞—Å–∫–æ–ª—å–∫–æ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –¥–æ–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–≥–æ –≤–∞—Ä–∏–∞–Ω—Ç–∞ –∞–Ω—Ç–∏—Ç–µ–ª–∞ –ø–æ—Å–ª–µ —Ä–∞—É–Ω–¥–∞ –æ—Ç–±–æ—Ä–∞, –∏ –Ω–∞ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤–ª–∏—è—é—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å —Å–≤—è–∑—ã–≤–∞–Ω–∏—è (–ö–î), –Ω–æ –∏ –¥—Ä—É–≥–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã, —Ç–∞–∫–∏–µ –∫–∞–∫ —É—Ä–æ–≤–µ–Ω—å —ç–∫—Å–ø—Ä–µ—Å—Å–∏–∏ –±–µ–ª–∫–∞, –µ–≥–æ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –∏ —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–∏–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã –ø—Ä–æ—Ç–æ–∫–æ–ª–∞ –æ—Ç–±–æ—Ä–∞ (–∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è –∞–Ω—Ç–∏–≥–µ–Ω–∞, –∂–µ—Å—Ç–∫–æ—Å—Ç—å –ø—Ä–æ–º—ã–≤–∫–∏ –∏ —Ç.–¥.).

log10‚Äã(–ö–î[nM]‚Äã)‚âàa‚àíb√ólog_enrichment.


| –ò—Å—Ç–æ—á–Ω–∏–∫                                                | –£—Å–ª–æ–≤–∏–µ                                     | a         | b     | –ü—Ä–∏–º–µ—á–∞–Ω–∏–µ                           |
| ------------------------------------------------------- | ------------------------------------------- | --------- | ----- | ------------------------------------ |
| Adams et al., 2016, Cell Systems                      | Yeast display, binding to antigen           | ‚âà 3.0     | ‚âà 0.9 | log_enrichment=0 ‚Üí –ö–î‚âà1 ŒºM           |
| Whitehead et al., 2012, Nat Biotech                   | Phage display, antibody affinity maturation | ‚âà 2.5‚Äì3.0 | ‚âà 1.0 | Œîlog_enrichment=1 ‚Üí √ó10 —É–ª—É—á—à–µ–Ω–∏–µ –ö–î |
| Fowler et al., 2010, Nature Methods (DMS Œ≤-lactamase) | Enzyme activity proxy                       | ‚âà 3.5     | ‚âà 0.7 | –ú–µ–Ω–µ–µ –ø—Ä—è–º–∞—è —Å–≤—è–∑—å                   |
| Bloom Lab datasets (RBD DMS, 2020‚Äì2022)               | SARS-CoV-2 RBD binding to ACE2              | ‚âà 2.7     | ‚âà 0.8 | –®–∏—Ä–æ–∫–æ –ø—Ä–∏–º–µ–Ω—è–µ–º–∞—è –∞–ø–ø—Ä–æ–∫—Å–∏–º–∞—Ü–∏—è     |

–¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —É–Ω–∏–≤–µ—Ä—Å–∞–ª—å–Ω–∞—è –∞–ø–ø—Ä–æ–∫—Å–∏–º–∞—Ü–∏—è –º–æ–∂–µ—Ç –±—ã—Ç—å:
log10(–ö–î[nM])=3.0‚àí1.0√ólog_enrichment
	‚Äã
–¢–æ–≥–¥–∞:

| –ö–î (–Ω–ú)         | log‚ÇÅ‚ÇÄ(–ö–î) | –ü—Ä–∏–º–µ—Ä–Ω—ã–π log_enrichment |
| --------------- | --------- | ------------------------ |
| 10‚Å¥ nM (10 ŒºM)  | 4         | ‚âà ‚àí1                     |
| 10¬≥ nM (1 ŒºM)   | 3         | ‚âà 0                      |
| 10¬≤ nM (100 nM) | 2         | ‚âà +1                     |
| 10 nM           | 1         | ‚âà +2                     |
| 1 nM            | 0         | ‚âà +3                     |

–í—ã–±–∏—Ä–∞–µ–º –ø–æ—Ä–æ–≥ +1
–ü—Ä–æ–≤–∞–ª–∏–¥–∏—Ä–æ–≤–∞—Ç—å –ø–æ—Ä–æ–≥–∏ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö ‚Äî –Ω–∞ —Å–ª—É—á–∞—è—Ö, –∫–æ–≥–¥–∞ –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–∞ –µ—Å—Ç—å –∏–∑–º–µ—Ä–µ–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Ç–∏–ø–æ–≤ –∞—Ñ—Ñ–∏–Ω–æ—Å—Ç–∏ –Ω–µ –ø–æ–ª—É—á–∏–ª–æ—Å—å, —Ç–∞–∫ –∫–∞–∫ —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ –Ω–µ–º–Ω–æ–≥–æ, –∫–æ–≥–¥–∞ –ø–µ—Ä–µ—Å–µ–∫–∞—é—Ç—Å—è –Ω–µ—Å–∫–æ–ª—å–∫–æ –∑–∞–ø–∏—Å–µ–π —Å –æ–¥–∏–Ω–∞–∫–æ–≤—ã–º–∏ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—è–º–∏, –Ω–æ —Ä–∞–∑–Ω—ã–º–∏ Affinity Type.


##### delta_g

–î–∞–Ω–Ω—ã–µ –¥–∞—Ç–∞—Å–µ—Ç–∞ BioMap —Å–æ–¥–µ—Ä–∂–∞—Ç –∏–∑–º–µ—Ä–µ–Ω–Ω—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è —Å–≤–æ–±–æ–¥–Ω–æ–π —ç–Ω–µ—Ä–≥–∏–∏ —Å–≤—è–∑—ã–≤–∞–Ω–∏—è (ŒîG) –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–æ–≤ –∞–Ω—Ç–∏—Ç–µ–ª –∏ –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤, —Ä–∞—Å—Å—á–∏—Ç–∞–Ω–Ω—ã–µ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö –∏–∑ PDB [He et al., 2024; doi:10.48550/arXiv.2411.15215; Zhang et al., 2025; doi:10.1101/2025.11.24.690097].
–°–≤—è–∑—å –º–µ–∂–¥—É –∫–æ–Ω—Å—Ç–∞–Ω—Ç–æ–π –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ (K_D) –∏ —Å–≤–æ–±–æ–¥–Ω–æ–π —ç–Ω–µ—Ä–≥–∏–µ–π —Å–≤—è–∑—ã–≤–∞–Ω–∏—è –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç—Å—è —É—Ä–∞–≤–Ω–µ–Ω–∏–µ–º:

ŒîG = R √ó T √ó ln(K_D)

–≥–¥–µ R = 1.987 √ó 10‚Åª¬≥ kcal/(mol¬∑K), –∞ T = 298 K (25 ¬∞C).
–ü—Ä–∏ —Ç–∞–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö –ø–æ—Ä–æ–≥ K_D = 100 –Ω–ú —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –ø—Ä–∏–±–ª–∏–∑–∏—Ç–µ–ª—å–Ω–æ ŒîG ‚âà ‚àí9.5 kcal/mol.
–≠—Ç–æ –∑–Ω–∞—á–µ–Ω–∏–µ –º–æ–∂–Ω–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø–æ—Ä–æ–≥–æ–≤–æ–≥–æ –∫—Ä–∏—Ç–µ—Ä–∏—è –¥–ª—è –≤—ã–¥–µ–ª–µ–Ω–∏—è –≤—ã—Å–æ–∫–æ–∞—Ñ—Ñ–∏–Ω–Ω—ã—Ö –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π –≤ BioMap (—Ç–æ –µ—Å—Ç—å ŒîG < ‚àí9.5 kcal/mol —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Å–∏–ª—å–Ω–æ–º—É —Å–≤—è–∑—ã–≤–∞–Ω–∏—é).

##### ddg

–ê–≤—Ç–æ—Ä—ã –¥–∞—Ç–∞—Å–µ—Ç–∞ –Ω–µ –∑–∞–¥–∞–≤–∞–ª–∏ —É–Ω–∏–≤–µ—Ä—Å–∞–ª—å–Ω—ã–π ¬´–ø–æ—Ä–æ–≥ —Å–∏–ª—å–Ω–æ–≥–æ —Å–≤—è–∑—ã–≤–∞–Ω–∏—è¬ª, –æ–¥–Ω–∞–∫–æ –≤ —Å–∞–º–∏—Ö –¥–∞–Ω–Ω—ã—Ö –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –¥–∏–∞–ø–∞–∑–æ–Ω ŒîG ‚âà –æ—Ç ‚àí4 –¥–æ ‚àí15 kcal/mol, —á—Ç–æ –ø–æ–¥—Ä–∞–∑—É–º–µ–≤–∞–µ—Ç, —á—Ç–æ ŒîŒîG ‚âà +1.5 kcal/mol —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –æ—Å–ª–∞–±–ª–µ–Ω–∏—é –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ –¥–æ K_D ‚âà 100 –Ω–ú.

–í –Ω–∞–±–æ—Ä–∞—Ö –¥–∞–Ω–Ω—ã—Ö Ab-Bind –∏ SKEMPI v2.0 —Å–≤–æ–±–æ–¥–Ω–∞—è —ç–Ω–µ—Ä–≥–∏—è —Å–≤—è–∑—ã–≤–∞–Ω–∏—è (ŒîG) –∏–∑–º–µ—Ä—è–µ—Ç—Å—è –≤ –∫–∏–ª–æ–∫–∞–ª–æ—Ä–∏—è—Ö –Ω–∞ –º–æ–ª—å, –∞ –∏–∑–º–µ–Ω–µ–Ω–∏—è –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –ø—Ä–∏ –º—É—Ç–∞—Ü–∏—è—Ö –≤—ã—Ä–∞–∂–∞—é—Ç—Å—è —á–µ—Ä–µ–∑ —Ñ–æ—Ä–º—É–ª—É ŒîŒîG = ŒîG_mut ‚àí ŒîG_wt (–≤ kcal/mol).
–°–æ–≥–ª–∞—Å–Ω–æ –¥–∞–Ω–Ω—ã–º –æ–±–µ–∏—Ö –∫–æ–ª–ª–µ–∫—Ü–∏–π, –¥–∏–∞–ø–∞–∑–æ–Ω –Ω–∞–±–ª—é–¥–∞–µ–º—ã—Ö ŒîG –æ–±—ã—á–Ω–æ –ª–µ–∂–∏—Ç –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö –æ—Ç ‚àí4 –¥–æ ‚àí15 kcal/mol, —á—Ç–æ —Å–æ–≥–ª–∞—Å—É–µ—Ç—Å—è —Å –¥–∏–∞–ø–∞–∑–æ–Ω–æ–º –∫–æ–Ω—Å—Ç–∞–Ω—Ç –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ K_D ‚âà mM ‚Äì pM [Hummer et al., 2025; doi:10.1038/s43588-025-00823-8; Geng et al., 2019; doi:10.1002/wcms.1410].

–ê–≤—Ç–æ—Ä—ã —ç—Ç–∏—Ö –±–∞–∑ –¥–∞–Ω–Ω—ã—Ö –Ω–µ –≤–≤–æ–¥–∏–ª–∏ –µ–¥–∏–Ω–æ–≥–æ ¬´–ø–æ—Ä–æ–≥–∞ —Å–∏–ª—å–Ω–æ–≥–æ —Å–≤—è–∑—ã–≤–∞–Ω–∏—è¬ª –≤ —Ç–µ—Ä–º–∏–Ω–∞—Ö ŒîŒîG, –æ–¥–Ω–∞–∫–æ —Å–æ–ø–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ —Å –∫–æ–Ω—Å—Ç–∞–Ω—Ç–æ–π –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ø–æ —É—Ä–∞–≤–Ω–µ–Ω–∏—é ŒîG = R √ó T √ó ln(K_D) (–ø—Ä–∏ R = 1.987 √ó 10‚Åª¬≥ kcal¬∑mol‚Åª¬π¬∑K‚Åª¬π –∏ T = 298 K) –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ –ø–µ—Ä–µ—Ö–æ–¥ –æ—Ç ŒîG = ‚àí11 –∫ ‚àí9.5 kcal/mol —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –æ—Å–ª–∞–±–ª–µ–Ω–∏—é —Å—Ä–æ–¥—Å—Ç–≤–∞ –ø—Ä–∏–º–µ—Ä–Ω–æ –¥–æ K_D ‚âà 100 –Ω–ú.
–¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, ŒîŒîG ‚âà +1.5 kcal/mol –º–æ–∂–Ω–æ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∫–∞–∫ –ø–æ—Ä–æ–≥–æ–≤–æ–µ —É—Ö—É–¥—à–µ–Ω–∏–µ —Å—Ä–æ–¥—Å—Ç–≤–∞, —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏—é –∫–ª–∞—Å—Å–∞ ¬´–≤—ã—Å–æ–∫–æ–∞—Ñ—Ñ–∏–Ω–Ω–æ–≥–æ¬ª —Å–≤—è–∑—ã–≤–∞–Ω–∏—è –¥–æ —Å—Ä–µ–¥–Ω–µ–≥–æ.

–ü–æ–¥–æ–±–Ω—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è —Ç–∞–∫–∂–µ –≤—Å—Ç—Ä–µ—á–∞—é—Ç—Å—è –≤ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –æ—Ü–µ–Ω–∫–∞—Ö —Ç–æ—á–Ω–æ—Å—Ç–∏ –º–æ–¥–µ–ª–µ–π –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è ŒîŒîG. –°—Ä–µ–¥–Ω–µ–∫–≤–∞–¥—Ä–∞—Ç–∏—á–Ω–∞—è –æ—à–∏–±–∫–∞ (RMSE) –ª—É—á—à–∏—Ö –º–æ–¥–µ–ª–µ–π, –æ–±—É—á–µ–Ω–Ω—ã—Ö –Ω–∞ –¥–∞–Ω–Ω—ã—Ö SKEMPI v2 –∏ Ab-Bind, —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –ø–æ—Ä—è–¥–∫–∞ 1‚Äì1.5 kcal/mol, —á—Ç–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç —Ñ–∏–∑–∏—á–µ—Å–∫–∏–π –º–∞—Å—à—Ç–∞–± –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏ —ç—Ç–æ–π –≤–µ–ª–∏—á–∏–Ω—ã [Zhang et al., 2024; doi:10.1093/bioinformatics/btae233; Lan et al., 2024; doi:10.1038/s42256-024-00803-z].

##### elisa_mut_to_wt_ratio
–æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ—Å—Ç–∏ ELISA-—Å–∏–≥–Ω–∞–ª–∞ –º—É—Ç–∞–Ω—Ç–∞ –∫ –¥–∏–∫–æ–º—É —Ç–∏–ø—É (WT) –ø—Ä–∏ —Å–≤—è–∑—ã–≤–∞–Ω–∏–∏ —Å —Ç–µ–º –∂–µ –∞–Ω—Ç–∏–≥–µ–Ω–æ–º.
ELISA ratio = SignalWT / Signalmut

–¢–∞–±–ª–∏—Ü–∞ X. –≠–º–ø–∏—Ä–∏—á–µ—Å–∫–∞—è –∫–∞–ª–∏–±—Ä–æ–≤–∫–∞ (—Ç–∏–ø–∏—á–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ). –ü–æ—Å—Ç—Ä–æ–µ–Ω–æ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö –∏–∑ Carter et al., Methods Enzymol., 1994 –∏ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö –∫–∞–ª–∏–±—Ä–æ–≤–æ–∫ ELISA vs –ö–î
| –ö–î (–º—É—Ç–∞–Ω—Ç) | –ö–î/WT | ELISA ratio (–º—É—Ç/WT) | –ò–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è            |
| ----------- | ----- | -------------------- | ------------------------ |
| 10 nM       | 0.1√ó  | ‚âà 1.8‚Äì2.0            | –û—á–µ–Ω—å –≤—ã—Å–æ–∫–∞—è –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å |
| 100 nM      | 1√ó    | ‚âà 1.0                | –°—Ä–µ–¥–Ω—è—è (—Ä–µ—Ñ–µ—Ä–µ–Ω—Å WT)    |
| 1 ¬µM        | 10√ó   | ‚âà 0.5                | –°—Ä–µ–¥–Ω—è—è/–Ω–∏–∑–∫–∞—è           |
| 10 ¬µM       | 100√ó  | ‚âà 0.2‚Äì0.3            | –°–ª–∞–±–æ–µ —Å–≤—è–∑—ã–≤–∞–Ω–∏–µ        |

üìò –û—Å–Ω–æ–≤–Ω—ã–µ —Å—Ç–∞—Ç—å–∏

Heinrich et al., 2010 ‚Äì Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity

Journal of Immunological Methods
‚ñ∏ –°—Ä–∞–≤–Ω–µ–Ω–∏–µ –ö–î, –∏–∑–º–µ—Ä–µ–Ω–Ω—ã—Ö –º–µ—Ç–æ–¥–∞–º–∏ ELISA –∏ SPR. –ü–æ–∫–∞–∑–∞–Ω–æ, —á—Ç–æ ELISA –¥–∞—ë—Ç —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏ –∑–∞–≤—ã—à–µ–Ω–Ω—ã–µ (–º–µ–Ω–µ–µ —á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–µ) –∑–Ω–∞—á–µ–Ω–∏—è –ö–î, –Ω–æ —Ö–æ—Ä–æ—à–æ –∫–æ—Ä—Ä–µ–ª–∏—Ä—É–µ—Ç (R¬≤ ‚âà 0.8) –ø—Ä–∏ –ö–î < 1 ¬µM.

Liang et al., 2007 ‚Äì Detection of high- and low-affinity antibodies against a human monoclonal antibody using various technology platforms

Assay and Drug Development Technologies
‚ñ∏ –°—Ä–∞–≤–Ω–∏–≤–∞–µ—Ç ELISA, SPR –∏ ECL. –î–ª—è –∞–Ω—Ç–∏—Ç–µ–ª —Å –ö–î –æ—Ç 0.05 –¥–æ 300 nM –ø–æ–∫–∞–∑–∞–Ω–æ:
‚Äì ELISA —Ç–µ—Ä—è–µ—Ç —á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø—Ä–∏ –ö–î > 100 nM;
‚Äì log(ELISA signal) ‚âà ‚Äì0.9 √ó log(–ö–î) + const.

Yoon & Lee, 1995 ‚Äì Measurement of the Affinity Constant of Monoclonal Antibody to Human Apolipoprotein A-I by ELISA

‚ñ∏ –ü—Ä—è–º–æ–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –ö–î –∏–∑ ELISA (—á–µ—Ä–µ–∑ —É—Ä–∞–≤–Ω–µ–Ω–∏–µ –°–∫–∞—Ç—á–∞—Ä–¥–∞). –ü–æ–ª—É—á–µ–Ω—ã –ö–î ‚âà 0.6‚Äì0.7 √ó 10‚Åª‚Åπ M, –º–µ—Ç–æ–¥ –≤–æ—Å–ø—Ä–æ–∏–∑–≤–æ–¥–∏–º –∏ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ —Å–æ–≥–ª–∞—Å—É–µ—Ç—Å—è —Å SPR.

Belitzky et al., 2022 ‚Äì Determining Binding Affinity (–ö–î) of Radiolabeled Antibodies to Immobilized Antigens

Journal of Visualized Experiments (JoVE)
‚ñ∏ –ü–æ—à–∞–≥–æ–≤—ã–π –ø—Ä–æ—Ç–æ–∫–æ–ª –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –ö–î —á–µ—Ä–µ–∑ –∏–º–º–æ–±–∏–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–π –∞–Ω—Ç–∏–≥–µ–Ω, –ø—Ä–∏–º–µ–Ω–∏–º—ã–π –∏ –∫ ELISA-–ø–æ–¥–æ–±–Ω—ã–º —Ñ–æ—Ä–º–∞—Ç–∞–º.

Zhao et al., 2025 ‚Äì Benchmark for Antibody Binding Affinity Maturation and Design

arXiv (AbBiBench dataset)
‚ñ∏ –í–∫–ª—é—á–∞–µ—Ç –±–æ–ª–µ–µ 180 000 –∏–∑–º–µ—Ä–µ–Ω–∏–π (–≤ —Ç. —á. ELISA-–∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –∏ –ö–î) –¥–ª—è —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–π –æ—Ü–µ–Ω–∫–∏ –º–æ–¥–µ–ª–µ–π —Å–≤—è–∑—ã–≤–∞–Ω–∏—è. –î–∞–Ω–Ω—ã–µ –º–æ–∂–Ω–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤—ã—Ä–∞–≤–Ω–∏–≤–∞–Ω–∏—è —à–∫–∞–ª (–ö–î ‚Üî ELISA).

##### ic_50

